An iPSC-derived blood-brain barrier to model neurodegeneration

01:054 months ago

The blood-brain barrier is a layer of cells that protects our brain from harmful compounds. However, due to this tight barrier, many drugs to treat neurological diseases cannot enter the brain either.
There are currently no good models to test these types of drugs. Henrique Nogueira Pinto is a PhD candidate at the Vrije Universiteit in Amsterdam. He is developing a blood-brain barrier model coupled to mini-brains. With this model, he aims to more reliably test how drugs can be transported over the blood-brain barrier and what their effect on the brain is.

Click on the info button for the full version of the video. Click here for a review of the current status of in vitro models for the blood-brain barrier.

Related

VHP4Safety project
Projects and initiatives
HealthToxicologyIn vitroIn silico

VHP4Safety project

This video explains how we are developing the Virtual Human Platform to improve safety assessment with human-relevant data and models. VHP4Safety (https://vhp4safety.nl/) - the Virtual Human Platform for safety assessment - is a research project funded by the Dutch Research Council (NWO) program entitled the ‘Dutch Research Agenda: Research on Routes by Consortia (NWA-ORC).’ With a budget of over 10 million Euros, the project started on June 1, 2021 and will last for the duration of 5 years.
03:1610 hours ago
AI agents for safer science: How AI is Changing Chemical Risk Assessment
Innovation examples
HealthToxicologyIn silico

AI agents for safer science: How AI is Changing Chemical Risk Assessment

This video introduces a novel approach to chemical safety, where intelligent digital agents guided by large language models support scientists in making faster, more transparent decisions. By automating complex workflows and integrating tools like the OECD QSAR Toolbox, these agentic systems help prioritise research, reduce reliance on animal testing, and pave the way for safer, more sustainable innovation.
02:568 days ago
User Research in developing the virtual human platform
Innovation examples
ToxicologyPolicy

User Research in developing the virtual human platform

Digital tools can support the phasing out of animal-based tests and data in chemical risk assessment. This is one of the core promises of the Virtual Human Platform. The potential contribution of digitalization is linked to the acceptance and adoption of tools, methods, and data by stakeholders in several societal sectors. To facilitate the integration of stakeholders in the configuration of digital tools, Dr. Isaac Ortega Alvarado and colleagues gather insights from risk assessors in their role as users. Risk assessors are the ones who actualize chemical risk assessment and its standards through their practices. With this perspective, this research contributes to understanding the development and implementation of digital tools as embedded in social processes of construction and reception.
01:1530 days ago
Pro tips for making a video about your research
TPI.tv videos
Beginner

Pro tips for making a video about your research

Need some pro-tips to make your next video on animal-free innovations? Aniek and Victoria got some for you! In this video, they share why you should want to make a video about your research, tips about the content and format of an attractive video, and how to best share your video.
03:2530 days ago